Correction: Changes in Figures For Two of CIRM's New Goals
Rare diseases, 'novel targets' affected, CIRM explains
An item on Sept. 26, 2024, on the final approval of its new priorities, carried incorrect figures on two goals of the California stem cell and gene therapy agency.
The figures were official as of the Sept. 13 action by the agency’s Science Subcommittee but were changed with little notice for yesterday’s full board meeting of the California Institute for…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.